- Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
- Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
- Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
- Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
- PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
More ▼
Key statistics
On Tuesday, Senseonics Holdings Inc (SENS:ASQ) closed at 0.3988, 3.91% above its 52-week low of 0.3838, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4008 |
---|---|
High | 0.4082 |
Low | 0.3838 |
Bid | 0.40 |
Offer | 0.4346 |
Previous close | 0.3988 |
Average volume | 2.87m |
---|---|
Shares outstanding | 530.82m |
Free float | 503.78m |
P/E (TTM) | -- |
Market cap | 211.69m USD |
EPS (TTM) | -0.1023 USD |
Data delayed at least 15 minutes, as of Apr 23 2024.
More ▼